Kiniksa Pharmaceuticals to Report Second Quarter 2025 Financial Results on July聽29, 2025
Kiniksa Pharmaceuticals (Nasdaq: KNSA) has scheduled its second quarter 2025 financial results conference call and webcast for Tuesday, July 29, 2025 at 8:30 a.m. Eastern Time. The company will discuss its Q2 2025 financial performance and recent portfolio developments.
Investors can access the live webcast through the Investors & Media section on www.kiniksa.com. For telephone participation, interested parties must pre-register to receive dial-in details. A replay will be available on the company's website within 48 hours after the event.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) ha programmato la conference call e il webcast dei risultati finanziari del secondo trimestre 2025 per marted矛 29 luglio 2025 alle 8:30 AM ora Eastern. L'azienda discuter脿 le performance finanziarie del Q2 2025 e gli sviluppi recenti del portafoglio.
Gli investitori potranno seguire il webcast in diretta nella sezione Investors & Media su www.kiniksa.com. Per partecipare telefonicamente, 猫 necessario registrarsi in anticipo per ricevere i dettagli di accesso. Una registrazione sar脿 disponibile sul sito web dell'azienda entro 48 ore dall'evento.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) ha programado su llamada y webcast para los resultados financieros del segundo trimestre de 2025 para el martes 29 de julio de 2025 a las 8:30 a.m. hora del Este. La compa帽铆a discutir谩 su desempe帽o financiero del Q2 2025 y los desarrollos recientes en su cartera.
Los inversores pueden acceder al webcast en vivo a trav茅s de la secci贸n Investors & Media en www.kiniksa.com. Para participar por tel茅fono, los interesados deben registrarse previamente para recibir los detalles de acceso. Una repetici贸n estar谩 disponible en el sitio web de la compa帽铆a dentro de las 48 horas posteriores al evento.
Kiniksa Pharmaceuticals (雮橃姢雼�: KNSA)電� 2025雲� 2攵勱赴 鞛鞁れ爜 旎嵓霟办姢 旖� 氚� 鞗轨簮鞀ろ姼毳� 2025雲� 7鞗� 29鞚� 頇旍殧鞚� 鞓れ爠 8鞁� 30攵�(霃欕秬鞁滉皠)鞐� 鞓堨爼頄堨姷雼堧嫟. 須岇偓電� 2025雲� 2攵勱赴 鞛 靹标臣鞕� 斓滉芳 韽姼韽措Μ鞓� 臧滊皽 靷暛鞚� 雲检潣頃� 鞓堨爼鞛呺媹雼�.
韴瀽鞛愲摛鞚赌 www.kiniksa.com鞚� Investors & Media 靹轨厴鞚� 韱淀暣 霛检澊敫� 鞗轨簮鞀ろ姼鞐� 鞝戩啀頃� 靾� 鞛堨姷雼堧嫟. 鞝勴檾 彀胳棳毳� 鞗愴暊 瓴届毎, 靷爠 霌彪鞚� 韱淀暣 鞝勴檾 鞝戩啀 鞝曤炒毳� 氚涭晞鞎� 頃╇媹雼�. 頄夓偓 頉� 48鞁滉皠 鞚措偞鞐� 須岇偓 鞗轨偓鞚错姼鞐愳劀 雼れ嫓氤搓赴臧� 鞝滉车霅╇媹雼�.
Kiniksa Pharmaceuticals (Nasdaq : KNSA) a programm茅 sa conf茅rence t茅l茅phonique et webcast des r茅sultats financiers du deuxi猫me trimestre 2025 pour le mardi 29 juillet 2025 脿 8h30, heure de l鈥橢st. La soci茅t茅 discutera de ses performances financi猫res du T2 2025 ainsi que des d茅veloppements r茅cents de son portefeuille.
Les investisseurs peuvent acc茅der au webcast en direct via la section Investors & Media sur www.kiniksa.com. Pour participer par t茅l茅phone, il est n茅cessaire de s鈥檌nscrire 脿 l鈥檃vance afin de recevoir les d茅tails d鈥檃cc猫s. Une rediffusion sera disponible sur le site internet de la soci茅t茅 dans les 48 heures suivant l鈥櫭﹙茅nement.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) hat seine Telefonkonferenz und Webcast zu den Finanzergebnissen des zweiten Quartals 2025 f眉r Dienstag, den 29. Juli 2025 um 8:30 Uhr Eastern Time angesetzt. Das Unternehmen wird die finanzielle Leistung des Q2 2025 sowie aktuelle Entwicklungen im Portfolio besprechen.
Investoren k枚nnen den Live-Webcast 眉ber den Bereich Investors & Media auf www.kiniksa.com verfolgen. F眉r die telefonische Teilnahme ist eine vorherige Registrierung erforderlich, um Einwahldaten zu erhalten. Eine Aufzeichnung wird innerhalb von 48 Stunden nach der Veranstaltung auf der Unternehmenswebsite verf眉gbar sein.
- None.
- None.
LONDON, July 24, 2025 (GLOBE NEWSWIRE) -- 聽 (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, July 29, 2025 at 8:30 a.m. Eastern Time to report its second quarter 2025 financial results and recent portfolio execution.
A live webcast will be accessible through the Investors & Media section of the company鈥檚 website at . Individuals interested in participating in the call via telephone may register . Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the event will also be available on Kiniksa鈥檚 website within approximately 48 hours after the event.
About Kiniksa
Kiniksa is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating diseases by discovering, acquiring, developing, and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. Kiniksa鈥檚 portfolio of assets is based on strong biologic rationale or validated mechanisms and offers the potential for differentiation. For more information, please visit聽.
Every Second Counts! 庐
Kiniksa Investor & Media Contact
Jonathan Kirshenbaum
(781) 829-3949
FAQ
When is Kiniksa Pharmaceuticals (KNSA) reporting Q2 2025 earnings?
How can investors access Kiniksa's Q2 2025 earnings call?
Will there be a replay available of Kiniksa's Q2 2025 earnings call?
What topics will be covered in Kiniksa's Q2 2025 earnings call?
